Gastric Cancer,Gastrointestinal Cancer Trastuzumab Deruxtecan Shows Promise in HER2-Low Gastric Cancer: Phase II Exploratory Cohort Results May 22, 2023
Esophageal Cancer,Gastrointestinal Cancer Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment for Advanced Esophageal Cancer May 02, 2023
Esophageal Cancer,Gastrointestinal Cancer A Cost-Effectiveness Analysis on Pembrolizumab +Chemo vs. Chemo Alone for Advanced Esophageal Cancer Apr 28, 2023
Gastrointestinal Cancer,Liver Cancer KEYNOTE-240 Trail Assessed Pembrolizumab in Patients with Advanced Liver Cancer Apr 21, 2023
Gastrointestinal Cancer,Liver Cancer COSMIC-312: Evaluated Cabozantinib and Atezolizumab in Treatment-Naive Advanced HCC Apr 21, 2023
Gastrointestinal Cancer,Liver Cancer CheckMate-459 Study: Comparing Nivolumab to Sorafenib in Liver Cancer Apr 21, 2023
Gastrointestinal Cancer,Pancreatic Cancer NCI-MATCH Phase II: Tolerable TRAEs from Vismdegib Oral Intake Mar 27, 2023
Gastrointestinal Cancer,Pancreatic Cancer Phase 2 eNRGy Study: Zenocutuzumab for NRG1+ Cancers Assessment Mar 27, 2023